Literature DB >> 6087164

[Peptide chemistry today].

R Geiger.   

Abstract

Peptide chemistry has reached a plateau on which more work is devoted to the improvement of known basic principles than to the development of really new methods. As a consequence, routine syntheses of peptides concentrate on few protecting groups and coupling procedures only. The recent progress in purification of peptides by liquid chromatography helped to promote this trend. Meanwhile, recombinant technology permits the synthesis of proteins and possibly of some lower peptides, too. It cannot compete, however, with chemical solid-phase synthesis of a newly discovered peptide with up to about 40 amino acids in speed but may take over the synthesis for large-scale production. Peptides containing modified or non-natural structures, which are often superior to the natural compounds as drugs, will remain subject of chemical synthesis, too. Present research focuses on the role of peptide and protein factors in the immune response and on structure and biological activities of neuropeptides.

Mesh:

Substances:

Year:  1984        PMID: 6087164     DOI: 10.1007/bf00441335

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  13 in total

1.  Preparation and properties of an artificial antigen immunologically related to tobacco mosaic virus.

Authors:  F A ANDERER
Journal:  Biochim Biophys Acta       Date:  1963-04-02

2.  Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence.

Authors:  H Matsuo; Y Baba; R M Nair; A Arimura; A V Schally
Journal:  Biochem Biophys Res Commun       Date:  1971-06-18       Impact factor: 3.575

3.  Antibodies that react with predetermined sites on proteins.

Authors:  J G Sutcliffe; T M Shinnick; N Green; R A Lerner
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

4.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

5.  Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour.

Authors:  J Rivier; J Spiess; M Thorner; W Vale
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

6.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

7.  A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin.

Authors:  G Goldstein; M P Scheid; E A Boyse; D H Schlesinger; J Van Wauwe
Journal:  Science       Date:  1979-06-22       Impact factor: 47.728

8.  Potency and duration of action of the ACTH 4-9 analog (ORG 2766) as compared to ACTH 4-10 and [D-Phe7] ACTH 4-10 on active and passive avoidance behavior of rats.

Authors:  M Fekete; D De Wied
Journal:  Pharmacol Biochem Behav       Date:  1982-03       Impact factor: 3.533

9.  Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly.

Authors:  R Guillemin; P Brazeau; P Böhlen; F Esch; N Ling; W B Wehrenberg
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

10.  A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide.

Authors:  J P Burbach; G L Kovács; D de Wied; J W van Nispen; H M Greven
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

View more
  1 in total

1.  A model study directed towards the preparation of nucleopeptides via H-phosphonate intermediates.

Authors:  E Kuyl-Yeheskiely; C M Tromp; A H Schaeffer; G A van der Marel; J H van Boom
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.